STAGE 1 CT1B-T1CN0M0

Clinical trials for STAGE 1 CT1B-T1CN0M0 explained in plain language.

Never miss a new study

Get alerted when new STAGE 1 CT1B-T1CN0M0 trials appear

Sign up with your email to follow new studies for STAGE 1 CT1B-T1CN0M0, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for early breast cancer: 3-Drug combo trial seeks to shrink tumors before surgery

Disease control Recruiting now

This study is testing whether a combination of three drugs (pembrolizumab, carboplatin, and paclitaxel) can effectively shrink early-stage triple-negative breast cancer tumors before surgery. The goal is to see if this approach can help patients avoid more intensive chemotherapy …

Matched conditions: STAGE 1 CT1B-T1CN0M0

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

STAGE 1 CT1B-T1CN0M0

Get alerted when new STAGE 1 CT1B-T1CN0M0 trials appear

New hope for early breast cancer: 3-Drug combo trial seeks to shrink tumors before surgery